| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/08/2008 | US20080107720 Topical delivery of codrugs |
| 05/08/2008 | US20080107693 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences |
| 05/08/2008 | US20080107684 Immunotherapy; hypersensitivity; antiinflammatory agents; autoimmune disorders |
| 05/08/2008 | US20080107662 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis |
| 05/08/2008 | US20080107650 Administering (S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid for treatment of inflammatory bowel disease, Crohn's disease; corticosteroid free therapy |
| 05/08/2008 | US20080107620 Human Cytomegalovirus Immunotherapy |
| 05/08/2008 | DE202008002263U1 Gesundheitsförderndes Mittel und dessen Verwendung Health-promoting agent and its use |
| 05/08/2008 | CA2667997A1 Humanized anti-factor d antibodies and uses thereof |
| 05/08/2008 | CA2667963A1 3-aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/08/2008 | CA2664343A1 High affinity human antibodies to human il-4 receptor |
| 05/08/2008 | CA2663537A1 Il-17 receptor a antigen binding proteins |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 05/07/2008 | EP1918298A2 Peptide |
| 05/07/2008 | EP1918291A1 3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators |
| 05/07/2008 | EP1917961A1 Capsinoid containing composition |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1917010A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 05/07/2008 | EP1725553B1 Tetrahydropyridoindole derivatives |
| 05/07/2008 | EP1701736A4 Therapeutic agents and uses therefor |
| 05/07/2008 | EP1592680B1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/07/2008 | EP1480951B1 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | CN101175722A Azetidine derivatives as ccr-3 receptor antagonists |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101172161A Water-soluble polymers decorated G-CSF conjugates |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172125A Ganoderma lucidum liquid fermentate, composition containing the fermentate , preparation method and application of the same |
| 05/07/2008 | CN101172100A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172099A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101171965A Use of boraginaceae cynoglossum plants in producing health food |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/07/2008 | CN100386104C Immunopotentiating drugs |
| 05/07/2008 | CN100386086C Dispersed compound tablet of glycyrrhizic acid and glycyrrhizinate and its preparing process |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368423 Composition and method for treating chronic allograft rejection |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2345675C Two chamber cartridge for atomizers |
| 05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
| 05/06/2008 | CA2294352C Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6] cyclohepta[1,2-b]pyridine |
| 05/06/2008 | CA2239694C Indane dimer compounds and their pharmaceutical use |
| 05/02/2008 | WO2008051862A2 Immunopotentiating compositions comprising beta-1,3/1,6-d-glucan and uses thereof |
| 05/02/2008 | WO2008051763A1 Cathepsin proteases inhibitors |
| 05/02/2008 | WO2008051440A1 Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione |
| 05/02/2008 | WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008049874A1 Piperidyl-propane-thiol ccr3 modulators |
| 05/02/2008 | WO2008049424A2 Pharmaceutical composition for the treatment of allergic diseases |
| 05/02/2008 | WO2008049231A1 Tissue targeted antigenic activation of the immune response to treat cancers |
| 05/02/2008 | WO2008049197A1 Composition and method for reducing inflammation |
| 05/02/2008 | WO2008033932A3 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 05/02/2008 | WO2008031438A3 Treatment of asthma, eczema and/or allergy using non-pathogenic organisms |
| 05/02/2008 | WO2008031437A3 Treatment of asthma, eczema and/or allergy using antibiotics |
| 05/02/2008 | WO2008015014A3 Cystatin from nematodes in the treatment of autoimmune or allergic diseases |
| 05/02/2008 | WO2008014410A3 Zimlig2 polynucleotides and polypeptides and methods of use |
| 05/02/2008 | WO2008010225A3 Enhancement of regulatory t cells' activity using statins |
| 05/02/2008 | WO2007144503A3 Novel process for preparing nitrones and n-hydroxylamines comprising at least one hydroxyl group, and products thus obtained |
| 05/02/2008 | WO2007052172A8 Methods for fusion polypeptide delivery into a cell |
| 05/02/2008 | CA2667816A1 Compositions and methods for inhibiting cathepsin proteases |
| 05/02/2008 | CA2667547A1 Piperidyl-propane-thiol ccr3 modulators |
| 05/02/2008 | CA2667263A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 05/02/2008 | CA2666965A1 Crystal modifications of -3-(1h-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione |
| 05/02/2008 | CA2666609A1 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 05/02/2008 | CA2666606A1 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 05/01/2008 | US20080103215 Screening Method |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103099 Apoptin-associating protein |
| 05/01/2008 | US20080102090 Mixture with surfactant; therapy for muscular paralysis; greater intramuscular safety margin; selective action on inhibition of pain-related (nociceptive) nerve cell function |
| 05/01/2008 | US20080102085 Vaccines for treatment of Aids; protein or polynucleotide is delivered via a bombardment approach |
| 05/01/2008 | US20080102071 T cell inhibitory receptor compositions and uses thereof |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 04/30/2008 | EP1916304A2 Antigenic polypeptides associated with multiple sclerosis and uses |
| 04/30/2008 | EP1916245A1 Indole derivative having pgd2 receptor antagonist activity |
| 04/30/2008 | EP1916241A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 04/30/2008 | EP1916020A2 Preventives and/or remedies for systemic lupus erythematosus containing anti-IL-6 receptor antibody as the active ingredient |
| 04/30/2008 | EP1915994A1 Cyclic amine derivative containing ppar regulator |
| 04/30/2008 | EP1915398A2 Human anti-b7rp1 neutralizing antibodies |
| 04/30/2008 | EP1915350A1 Amide derivatives |
| 04/30/2008 | EP1647599B1 Quantitative method for detecting yessotoxins in fishery products based on the activation caused by the toxin in cellular phosphodiesterase |
| 04/30/2008 | EP1444248B1 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/30/2008 | EP1212063B9 Topical azathioprine for the treatment of oral autoimmune diseases |
| 04/30/2008 | EP1183360B1 Modified cytokine for its stabilisation |
| 04/30/2008 | EP1127072B1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |